Twilight Venture Partners
Overview
Twilight Venture Partners invests exclusively in early-stage biotech and med tech companies.
Investment Focus
- Early-stage life science companies
- Focus on biotechnology and medical technology sectors
- Potential for significant impact in the Asian market
- Visionary entrepreneurs with innovative ideas
- Companies poised to reshape healthcare and improve lives
- Alignment with the firm's values of integrity and excellence
Portfolio Companies
Reach Twilight Venture Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Twilight Venture Partners
What sectors does Twilight Venture Partners invest in?
Twilight Venture Partners invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Indiana, United States. Twilight Venture Partners is listed as a vc in the ConnectSafely investor database.
What stage does Twilight Venture Partners invest at?
Twilight Venture Partners backs companies at Seed, Series A, Series B, Growth, Late Stage and Pre-IPO, writing cheques of 1M - 50M.
Which regions does Twilight Venture Partners invest in?
Twilight Venture Partners invests across United States, Japan, Australia, Singapore, China and India.
What companies has Twilight Venture Partners invested in?
Twilight Venture Partners's portfolio includes MBX Biosciences, BioStorage Technologies, NeoChord, Nico, Wap Guro, MaterMend and Sunkofa Energy.
Last updated · Source: ConnectSafely investor database